Thyroid dysfunctions induced by tyrosine kinase inhibitors.
作者： Poupak Fallahi , Silvia M Ferrari , Roberto Vita , Andrea Di Domenicantonio , Alda Corrado
DOI: 10.1517/14740338.2014.913021
关键词:
摘要: … assessment of TKI-induced thyroid dysfunctions by sunitinib, sorafenib, … thyroid dysfunction in these patients and the controversies regarding treatment with thyroid hormone (TH…
core.ac.uk
informahealthcare.com参考文章(89)
Robert I. Haddad, New Developments in Thyroid Cancer Journal of The National Comprehensive Cancer Network. ,vol. 11, pp. 705- 707 ,(2013) , 10.6004/JNCCN.2013.0207
Manuela Schmidinger, Ursula M. Vogl, Marija Bojic, Wolfgang Lamm, Harald Heinzl, Andrea Haitel, Martin Clodi, Gero Kramer, Christoph C. Zielinski, Hypothyroidism in patients with renal cell carcinoma: blessing or curse? Cancer. ,vol. 117, pp. 534- 544 ,(2011) , 10.1002/CNCR.25422
Francesco Torino, Salvatore Maria Corsello, Raffaele Longo, Agnese Barnabei, Giampietro Gasparini, Hypothyroidism related to tyrosine kinase inhibitors: an emerging toxic effect of targeted therapy. Nature Reviews Clinical Oncology. ,vol. 6, pp. 219- 228 ,(2009) , 10.1038/NRCLINONC.2009.4
J DEGROOT, B ZONNENBERG, J PLUKKER, W VANDERGRAAF, T LINKS, Imatinib induces hypothyroidism in patients receiving levothyroxine. Clinical Pharmacology & Therapeutics. ,vol. 78, pp. 433- 438 ,(2005) , 10.1016/J.CLPT.2005.06.010
J. M. Stommel, A. C. Kimmelman, H. Ying, R. Nabioullin, A. H. Ponugoti, R. Wiedemeyer, A. H. Stegh, J. E. Bradner, K. L. Ligon, C. Brennan, L. Chin, R. A. DePinho, Coactivation of Receptor Tyrosine Kinases Affects the Response of Tumor Cells to Targeted Therapies Science. ,vol. 318, pp. 287- 290 ,(2007) , 10.1126/SCIENCE.1142946
Judy W King, Siow-Ming Lee, Axitinib for the treatment of advanced non-small-cell lung cancer Expert Opinion on Investigational Drugs. ,vol. 22, pp. 765- 773 ,(2013) , 10.1517/13543784.2013.775243
Andrew K. Salem, Mike S. Fenton, Kenneth M. Marion, Jerome M. Hershman, Effect of sunitinib on growth and function of FRTL-5 thyroid cells. Thyroid. ,vol. 18, pp. 631- 635 ,(2008) , 10.1089/THY.2007.0336
David Garfield, Aleck Hercbergs, Paul Davis, Unanswered questions regarding the management of sunitinib-induced hypothyroidism. Nature Reviews Clinical Oncology. ,vol. 4, pp. 674- 674 ,(2007) , 10.1038/NCPONC0998
Shuichi Sato, Kazuhisa Muraishi, Junichi Tani, Yuko Sasaki, Ichiro Tokubuchi, Yuji Tajiri, Kentaro Yamada, Shigetaka Suekane, Jiro Miyajima, Kei Matsuoka, Yuji Hiromatsu, Clinical characteristics of thyroid abnormalities induced by sunitinib treatment in Japanese patients with renal cell carcinoma. Endocrine Journal. ,vol. 57, pp. 873- 880 ,(2010) , 10.1507/ENDOCRJ.K10E-130
Alessandro Antonelli, Poupak Fallahi, Silvia Martina Ferrari, Caterina Mancusi, Michele Colaci, Libero Santarpia, Clodoveo Ferri, RET TKI: Potential Role in Thyroid Cancers Current Oncology Reports. ,vol. 14, pp. 97- 104 ,(2012) , 10.1007/S11912-012-0217-0